Riddhi Siddhi Gluco Biols (BOM:524480) EBIT: ₹481 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524480 Riddhi Siddhi Gluco Biols Ltd BOM:524480
52 GF Score
Price ₹707.20
GF Value ₹562.61
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Riddhi Siddhi Gluco Biols EBIT?

Riddhi Siddhi Gluco Biols BOM:524480 -0.62% 52 EBIT is ₹481 Mil as of Mar. 2026. GuruFocus rates BOM:524480 with a GF Score™ of 52/100 and a GF Value™ of ₹562.61 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Riddhi Siddhi Gluco Biols's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was ₹9 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹481 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Riddhi Siddhi Gluco Biols's annualized ROC % for the quarter that ended in Mar. 2026 was -2.29%. Riddhi Siddhi Gluco Biols's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 0.68%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Riddhi Siddhi Gluco Biols's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 6.81%.


Riddhi Siddhi Gluco Biols  (BOM:524480) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Riddhi Siddhi Gluco Biols's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-403.848 * ( 1 - 0% )/( (0 + 17653.706)/ 1 )
=-403.848/17653.706
=-2.29 %

where

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=18909.025 - 143.505 - ( 1111.814 - max(0, 1777.929 - 6933.148+1111.814))
=17653.706

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Riddhi Siddhi Gluco Biols's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=36.304/( ( (0 + max(0, 0)) + (4262.105 + max(1038.211, 0)) )/ 1 )
=36.304/( ( 0 + 5300.316 )/ 1 )
=36.304/5300.316
=0.68 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0 + 0 + 0)
=0

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(82.345 + 438.283 + 1139.313) - (143.505 + 0 + 478.225)
=1038.211

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Riddhi Siddhi Gluco Biols's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=480.762/7055.334
=6.81 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Riddhi Siddhi Gluco Biols EBIT Related Terms


Riddhi Siddhi Gluco Biols EBIT Historical Data

* Premium members only.

The historical data trend for Riddhi Siddhi Gluco Biols's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Riddhi Siddhi Gluco Biols EBIT Chart

Riddhi Siddhi Gluco Biols Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 716.91 560.00 735.48 812.40 480.76

Riddhi Siddhi Gluco Biols Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 205.63 188.61 216.27 66.81 9.08

BOM:524480 vs CTVA, CF, MOS: EBIT Comparison

For the Agricultural Inputs subindustry, Riddhi Siddhi Gluco Biols's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Riddhi Siddhi Gluco Biols EV-to-EBIT vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, Riddhi Siddhi Gluco Biols's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Riddhi Siddhi Gluco Biols's EV-to-EBIT falls into.


BOM:524480
52GF Score
Riddhi Siddhi Gluco Biols Ltd BOM:524480
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Riddhi Siddhi Gluco Biols EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹481 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₹481 Mil mean?
Riddhi Siddhi Gluco Biols (BOM:524480) has a EBIT of ₹481 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Riddhi Siddhi Gluco Biols.
Is Riddhi Siddhi Gluco Biols' EBIT too high?
Riddhi Siddhi Gluco Biols' current EBIT is ₹481 Mil. Overall, Riddhi Siddhi Gluco Biols has a GF Score™ of 52/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Riddhi Siddhi Gluco Biols' EBIT compare to CTVA and CF?
Riddhi Siddhi Gluco Biols' EBIT of ₹481 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for an Agriculture company?
A good EBIT depends on the Agriculture industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Riddhi Siddhi Gluco Biols. Riddhi Siddhi Gluco Biols's current EBIT is ₹481 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Riddhi Siddhi Gluco Biols stock overvalued right now?
Based on GuruFocus' analysis, Riddhi Siddhi Gluco Biols (BOM:524480) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹562.61, compared to a current price of ₹707.20 — trading 25.7% above its estimated fair value. The current EBIT is ₹481 Mil. Riddhi Siddhi Gluco Biols' overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Riddhi Siddhi Gluco Biols (BOM:524480), the current EBIT is ₹481 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Riddhi Siddhi Gluco Biols (BOM:524480) Overvalued in 2026?

Based on GuruFocus' analysis, Riddhi Siddhi Gluco Biols stock appears to be overvalued. The current stock price of ₹707.20 is trading 25.7% above its estimated GF Value™ of ₹562.61. GuruFocus considers Riddhi Siddhi Gluco Biols to be Modestly Overvalued.

Key valuation signals for BOM:524480:

  • EBIT: ₹481 Mil
  • GF Value™: ₹562.61 vs. price of ₹707.20 (25.7% above fair value)
  • GF Score™: 52/100 with 6 warning signs

No single metric tells the full story. See the BOM:524480 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Riddhi Siddhi Gluco Biols Business Description

Address Ambali - Bopal Road, 10, Abhishree Corporate Park, Near Swagat Bunglows BRTS Bus Stop, Ambali, Ahmedabad, GJ, IND, 380 058
Riddhi Siddhi Gluco Biols Ltd is engaged in the business of generating and selling power through windmills and trading of agriculture and metal commodity items. The company operates in various business segments that include Wind Energy Generation and Commodity Trading Business. The company generates a majority of its revenue from the Trading business, which represents the income generated from the sale of agricultural commodities. Geographically, the company derives key revenue from India.
52GF Score

Get the complete analysis for BOM:524480

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹707.20
Price
₹562.61
GF Value